BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Sabre//Sabre VObject 4.5.8//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:Europe/Zurich
X-LIC-LOCATION:Europe/Zurich
TZURL:http://tzurl.org/zoneinfo/Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:19810329T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:19961027T030000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:news619@chemie.unibas.ch
DTSTAMP;TZID=Europe/Zurich:20250211T095320
DTSTART;TZID=Europe/Zurich:20250227T173000
SUMMARY:Rapid Kilo Scale Tactical delivery of Cardiovascular\, Renal\, Meta
 bolism and Oncology Targets Across AstraZeneca's Discovery-Process Portfol
 io
DESCRIPTION:Oliver Ring\, Senior Scientist (University AstraZeneca\, Early 
 Chemical Development\, Gothenburg\, Sweden)
X-ALT-DESC:Oliver Ring\, Senior Scientist (University AstraZeneca\, Early C
 hemical Development\, Gothenburg\, Sweden)
DTEND;TZID=Europe/Zurich:20250227T184500
END:VEVENT
END:VCALENDAR